Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19
2022 · JAMA · 149 citations
https://doi.org/10.1001/jama.2022.2910
S
Sheryl Ann Abdukahil
META Group(IT)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
44
Papers
1.5K
Citations
18
h-index
25
i10-index
Sheryl Ann Abdukahil is an academic researcher from META Group. The author has contributed to research in topics: COVID-19 Clinical Research Studies & Sepsis Diagnosis and Treatment & Respiratory Support and Mechanisms. The author has an h-index of 18, co-authored 38 publications.
Papers by this author
worksLong-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
2022 · JAMA · 134 citations
https://doi.org/10.1001/jama.2022.23257
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
2021 · Intensive Care Medicine · 96 citations
https://doi.org/10.1007/s00134-021-06448-5
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study
2021 · Infection · 80 citations
https://doi.org/10.1007/s15010-021-01599-5
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19
2022 · Scientific Data · 72 citations
https://doi.org/10.1038/s41597-022-01534-9
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19
2023 · International Journal of Epidemiology · 69 citations
https://doi.org/10.1093/ije/dyad012
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat